293 related articles for article (PubMed ID: 36560403)
1. Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer.
Fisher JG; Doyle ADP; Graham LV; Khakoo SI; Blunt MD
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560403
[TBL] [Abstract][Full Text] [Related]
2. NKG2A Expression Is Not
Mahaweni NM; Ehlers FAI; Sarkar S; Janssen JWH; Tilanus MGJ; Bos GMJ; Wieten L
Front Immunol; 2018; 9():1415. PubMed ID: 29988376
[TBL] [Abstract][Full Text] [Related]
3. NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.
Salomé B; Sfakianos JP; Ranti D; Daza J; Bieber C; Charap A; Hammer C; Banchereau R; Farkas AM; Ruan DF; Izadmehr S; Geanon D; Kelly G; de Real RM; Lee B; Beaumont KG; Shroff S; Wang YA; Wang YC; Thin TH; Garcia-Barros M; Hegewisch-Solloa E; Mace EM; Wang L; O'Donnell T; Chowell D; Fernandez-Rodriguez R; Skobe M; Taylor N; Kim-Schulze S; Sebra RP; Palmer D; Clancy-Thompson E; Hammond S; Kamphorst AO; Malmberg KJ; Marcenaro E; Romero P; Brody R; Viard M; Yuki Y; Martin M; Carrington M; Mehrazin R; Wiklund P; Mellman I; Mariathasan S; Zhu J; Galsky MD; Bhardwaj N; Horowitz A
Cancer Cell; 2022 Sep; 40(9):1027-1043.e9. PubMed ID: 36099881
[TBL] [Abstract][Full Text] [Related]
4. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
Kamiya T; Seow SV; Wong D; Robinson M; Campana D
J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
[TBL] [Abstract][Full Text] [Related]
5. Selinexor Enhances NK Cell Activation Against Malignant B Cells
Fisher JG; Walker CJ; Doyle AD; Johnson PW; Forconi F; Cragg MS; Landesman Y; Khakoo SI; Blunt MD
Front Oncol; 2021; 11():785635. PubMed ID: 34926302
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Natural Killer and CD8
Ravindranath MH; Filippone EJ; Devarajan A; Asgharzadeh S
Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):38-59. PubMed ID: 31009335
[TBL] [Abstract][Full Text] [Related]
7. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
Hò GT; Celik AA; Huyton T; Hiemisch W; Blasczyk R; Simper GS; Bade-Doeding C
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575403
[TBL] [Abstract][Full Text] [Related]
8.
Mac Donald A; Guipouy D; Lemieux W; Harvey M; Bordeleau LJ; Guay D; Roméro H; Li Y; Dion R; Béland K; Haddad E
Front Immunol; 2023; 14():1231916. PubMed ID: 37675109
[TBL] [Abstract][Full Text] [Related]
9. What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes.
Prašnikar E; Perdih A; Borišek J
Front Pharmacol; 2022; 13():925427. PubMed ID: 35991867
[TBL] [Abstract][Full Text] [Related]
10. NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E.
Battin C; Kaufmann G; Leitner J; Tobias J; Wiedermann U; Rölle A; Meyer M; Momburg F; Steinberger P
Immunology; 2022 Aug; 166(4):507-521. PubMed ID: 35596615
[TBL] [Abstract][Full Text] [Related]
11. The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells.
Kaulfuss M; Mietz J; Fabri A; Vom Berg J; Münz C; Chijioke O
Sci Rep; 2023 Jun; 13(1):10555. PubMed ID: 37386090
[TBL] [Abstract][Full Text] [Related]
12. Implications of NKG2A in immunity and immune-mediated diseases.
Wang X; Xiong H; Ning Z
Front Immunol; 2022; 13():960852. PubMed ID: 36032104
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.
McWilliams EM; Mele JM; Cheney C; Timmerman EA; Fiazuddin F; Strattan EJ; Mo X; Byrd JC; Muthusamy N; Awan FT
Oncoimmunology; 2016; 5(10):e1226720. PubMed ID: 27853650
[TBL] [Abstract][Full Text] [Related]
14. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
André P; Denis C; Soulas C; Bourbon-Caillet C; Lopez J; Arnoux T; Bléry M; Bonnafous C; Gauthier L; Morel A; Rossi B; Remark R; Breso V; Bonnet E; Habif G; Guia S; Lalanne AI; Hoffmann C; Lantz O; Fayette J; Boyer-Chammard A; Zerbib R; Dodion P; Ghadially H; Jure-Kunkel M; Morel Y; Herbst R; Narni-Mancinelli E; Cohen RB; Vivier E
Cell; 2018 Dec; 175(7):1731-1743.e13. PubMed ID: 30503213
[TBL] [Abstract][Full Text] [Related]
15. NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy.
Cazzetta V; Depierreux D; Colucci F; Mikulak J; Mavilio D
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831606
[TBL] [Abstract][Full Text] [Related]
16. [Advances in the role and mechanism of NK cell immune response mediated by NKG2A-HLA-E axis in viral infectious diseases].
Xue M; Xu X; Zhang X; Tang K; Zhang Y; Zhang C; Zhuang R; Jin B; Zhang Y; Yue C; Ma Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):273-278. PubMed ID: 38512038
[TBL] [Abstract][Full Text] [Related]
17. NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.
van Montfoort N; Borst L; Korrer MJ; Sluijter M; Marijt KA; Santegoets SJ; van Ham VJ; Ehsan I; Charoentong P; André P; Wagtmann N; Welters MJP; Kim YJ; Piersma SJ; van der Burg SH; van Hall T
Cell; 2018 Dec; 175(7):1744-1755.e15. PubMed ID: 30503208
[TBL] [Abstract][Full Text] [Related]
18. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
19. PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells.
Pesce S; Greppi M; Grossi F; Del Zotto G; Moretta L; Sivori S; Genova C; Marcenaro E
Front Immunol; 2019; 10():1242. PubMed ID: 31214193
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cell Receptor NKG2A/HLA-E Interaction Dependent Differential Thymopoiesis of Hematopoietic Progenitor Cells Influences the Outcome of HIV Infection.
Yunis EJ; Romero V; Diaz-Giffero F; Zuñiga J; Koka P
J Stem Cells; 2007; 2(4):237-248. PubMed ID: 19005583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
